Nicholas Verdini, MD Profile
Nicholas Verdini, MD

@nick_verdini

Followers
291
Following
9K
Statuses
357

Transitional Year PGY-1 | Future RadOnc Resident at Stanford ☢️ | Tufts School of Medicine Alum

Boston, MA
Joined June 2016
Don't wanna be here? Send us removal request.
@nick_verdini
Nicholas Verdini, MD
11 months
So incredibly excited and grateful for this opportunity. Thank you to the Stanford SCORE program for making it possible for me to do an away here @StanfordODME and to @ErinGillespieMD for being an incredible mentor
@StanfordRO_Res
Stanford Radiation Oncology Residents
11 months
🎉We are thrilled to announce our incredible #MATCH2024 doctors! So lucky to welcome you into our @StanfordRadOnc family! @AllisonZhong @UCSDMedSchool @nick_verdini @TuftsMedSchool @JKMatsui @OhioStateMed @erroncollins @Morehouse @MSMEDU #MATCHDAY @StanfordRO_Res
Tweet media one
6
6
54
@nick_verdini
Nicholas Verdini, MD
2 months
RT @pinheiroadam: Happy Small Business Saturday! 💙 Sweet Reads is the perfect gift for bakers and book lovers—an indie project made with l…
0
1
0
@nick_verdini
Nicholas Verdini, MD
4 months
RT @ARRO_org: Congrats to @nick_verdini on the ARRO @RO_Institute DEI Publication Award 👏 #astro24
Tweet media one
0
8
0
@nick_verdini
Nicholas Verdini, MD
4 months
RT @RadiantRehema: Congrats to @nick_verdini on his receipt of the ARRO/ROI joint DEI Publication Award, recognizing a trainee who has publ…
0
11
0
@nick_verdini
Nicholas Verdini, MD
6 months
RT @dtbergman: Proud to share our work compiling the landscape of funded #RadOnc away rotations for medical students! Pls RT to spread the…
0
12
0
@nick_verdini
Nicholas Verdini, MD
7 months
RT @Erman_Akkus: ☢️Celiac plexus radiation for pain management in pancreatic cancer @TheLancetOncol ✅At 3 weeks, 53% of the patients had…
0
48
0
@nick_verdini
Nicholas Verdini, MD
7 months
RT @apolo_andrea: Very proud of this #ClinicalTrial of Cabozantinib/Nivolumab #CaboNivo & Cabozantinib/ Nivolumab/Ipilimumab #CaboNivoIpi p…
0
27
0
@nick_verdini
Nicholas Verdini, MD
7 months
RT @JAMAOnc: Using ePROs to prompt direct patient trial invitations resulted in greater enrollment to a symptom-intervention trial than sta…
0
8
0
@nick_verdini
Nicholas Verdini, MD
9 months
Our paper, “When Is Telemedicine Appropriate in the Management of Head and Neck Cancer? A Mixed-Methods Assessment Among Patients and Physicians” is out now in JCO Oncology Practice! @TonyHungMDMBA @ErinGillespieMD
0
3
20
@nick_verdini
Nicholas Verdini, MD
10 months
RT @Applied_RadOnc: 📢 All new Student Scan out now! Check out hot topics in #RadiationOncology, an interview with @JillGunther MD, PhD, op…
0
5
0
@nick_verdini
Nicholas Verdini, MD
10 months
RT @JAMAOnc: Using ePROs to prompt direct patient trial invitations resulted in greater enrollment to a symptom-intervention trial than sta…
0
29
0
@nick_verdini
Nicholas Verdini, MD
10 months
0
0
0
@nick_verdini
Nicholas Verdini, MD
11 months
RT @StanfordODME: 🎉 Congratulations 🎉 to all of this year's SCORE students who matched at @StanfordMed. We can't wait to welcome you back t…
0
10
0
@nick_verdini
Nicholas Verdini, MD
11 months
@Dr_O_Kay Likewise!
0
0
2
@nick_verdini
Nicholas Verdini, MD
11 months
@MaryMahoney02 Thank you!!
0
0
0
@nick_verdini
Nicholas Verdini, MD
11 months
@JunMaoMD @StanfordODME @ErinGillespieMD Thank you Dr. Mao! Thank you for all the opportunities you’ve given me.
0
0
2
@nick_verdini
Nicholas Verdini, MD
11 months
@TrishaSantosMD @StanfordRadOnc So grateful for you! 💕
0
0
3
@nick_verdini
Nicholas Verdini, MD
11 months
RT @MSK_RadOnc: New by PGY2 Dr @NikMankuzhy with Dr Suzanne Wolden: Re-irradiation with hypofractionation for locally recurrent diffuse in…
0
11
0